The Analgesic Efficacy of Two Bupivacaine Concentrations for Combined Ilioinguinal and Iliohypogastric Nerve Block in Postherniorrhaphy Pain
Sponsored by Tanta University
About this trial
Last updated 3 years ago
Study ID
(IIIH) &(IINB) in pain control
Status
Not yet recruiting
Type
Interventional
Phase
Early Phase 1
Placebo
No
Accepting
18 to 60 Years
All
Trial Timing
Ended 2 years ago
What is this trial about?
The present study will be undertaken to compare the postoperative analgesic effect of 0.25%
bupivacaine and 0.5% bupivacaine for unilateral ilioinguinal and Iliohypogastric nerve block
after open inguinal hernia repair.
Primary outcome:
The time to first request for rescue analgesia.
Secondary outcome:
1. The post-operative pain in the form of NRS scores at rest & during movement at 0, 2, 4,
8, 12, 18 and 24 hours post-procedure.
2. The total 24 hour opioid consumption.
3. The incidence of complication related to nerve block (urinary retention, hematoma,
hypotension and arrhythmia).
4. Patient satisfaction
What are the participation requirements?
Inclusion Criteria
- Patients between 21 and 60 years age with the American Society of Anesthesiologists' status I or II scheduled for elective primary open inguinal hernia repair
Exclusion Criteria
1. Patient refusal.
2. Body mass index (BMI) >40 kg m2.
3. The presence of skin infection at the injection site.
4. Allergy to local anesthetic drugs.